TY  - JOUR
AU  - Sciurba,  F.C.
AU  - Puente Maestu, Luis
AU  - Pavord, Ian D.
PY  - 2025
DO  - 10.1056/NEJMoa2413181
UR  - https://hdl.handle.net/20.500.14352/129840
T2  - New England Journal of Medicine
AB  - BACKGROUND: In some patients with chronic obstructive pulmonary disease (COPD), type 2 inflammation may increase exacerbation risk and may be indicated by elevated blood eosinophil counts. Dupilumab, a fully human monoclonal antibody, blocks the...
LA  - eng
M2  - 10
PB  - Massachusetts Medical Society
TI  - Mepolizumab to PreventExacerbations of COPD with an Eosinophilic Phenotype
TY  - journal article
VL  - 392
ER  -